4//SEC Filing
Lockshin Curtis 4
Accession 0001683168-21-001020
CIK 0001534525other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:30 PM ET
Size
5.6 KB
Accession
0001683168-21-001020
Insider Transaction Report
Form 4
Lockshin Curtis
Chief Scientific Officer
Transactions
- Award
Stock Options
2021-03-18+50,000→ 50,000 totalExercise: $2.60Exp: 2031-03-18→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 18, 2021; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 18, 2022 and ending on March 18, 2024.
Documents
Issuer
Xenetic Biosciences, Inc.
CIK 0001534525
Entity typeother
Related Parties
1- filerCIK 0001383556
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 5:30 PM ET
- Size
- 5.6 KB